Tower Research Capital LLC (Trc) Armata Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,697 shares of ARMP stock, worth $4,293. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,697
Previous 3,367
49.6%
Holding current value
$4,293
Previous $10,000
30.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ARMP
# of Institutions
26Shares Held
1.42MCall Options Held
200Put Options Held
0-
Bank Of America Corp Charlotte, NC637KShares$1.61 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA159KShares$402,7980.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX110KShares$279,2660.01% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$252,9990.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.9KShares$252,7160.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $91.4M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...